Financials

News Ideas Discussions Technicals Forecast Seasonals

SNDX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Syndax Pharmaceuticals, Inc.

Total assets of SNDX for Q2 24 is 476.95 M USD, 12.17% less than the previous Q1 24. And total liabilities decreased by 16.68% in Q2 24 to 42.61 M USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—